iShares Nasdaq US Biotechnology UCITS ETF
BTEE.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$78.82M
Close$
Share Statistics
| Market cap | $78.82 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.02 (0.22%) |
| Earnings per Share | $- |
| Beta | 0.83 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About iShares Nasdaq US Biotechnology UCITS ETF
The iShares Nasdaq US Biotechnology UCITS ETF is structured to mirror the financial performance of a specific underlying index. This index comprises equities of biotechnology and pharmaceutical companies based in the US, which are primarily traded on the NASDAQ exchange.